FAQ Section What is Achieve Life Sciences’ core science and biotech platform? Achieve is a specialty pharmaceutical company focused on nicotine dependence. Its core development effort is cytisinicline ...

Top 5 Short-Term Skill-Based Courses After 12th Grade: The Class 12 board examinations have concluded in almost all states. Now, all that remains is the wait for the results. Passing the 12th grade ...

All the essential ingredients to make the DNA and RNA underpinning life on Earth have been discovered in samples collected from the asteroid Ryugu, scientists said Monday.

Advancing Life Science Construction 2026 brings together developers, owners, designers, and builders to tackle the unique challenges of delivering cutting-edge labs and manufacturing spaces. With ...

Tuesday “started as any other” for Tumbler Ridge, B.C, mom Cia Edmonds, but within hours she was sitting in the Vancouver children’s hospital with her 12-year-old daughter, Maya, “fighting for her ...

After February 12, 2026, life gets much easier for three zodiac signs. Thursday's astrological energy allows tension and emotional heaviness to finally lift. This day feels so much easier to deal with ...

A study released by Google Cloud late last year offered some eye-opening insights into where life sciences and healthcare executives are using artificial intelligence (AI), where they are not, and ...

Achieve Life Sciences is a single-asset microcap centered on cytisinicline, with an accepted NDA and a June 20, 2026, PDUFA. Cytisinicline's α4β2 partial agonism aims to reduce cravings and blunt ...

A Dalai Lama once said that our prime purpose in this life is to help others – and he may have been right. Scientists have found that having a positive impact on other people seems to be a key element ...

Chiba, Japan, January 12, 2026—A team at Japan’s National Institutes for Quantum Science and Technology (QST) has published a field-defining Perspective that places the societal payoff of quantum ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...